Holen Sie sich die Stockscreener-App
955.76
1.80%
16.92
Handel nachbörslich:
955.76
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$938.84
Offen:
$949.95
24-Stunden-Volumen:
646.13K
Relative Volume:
0.90
Marktkapitalisierung:
$111.43B
Einnahmen:
$403.43B
Nettoeinkommen (Verlust:
$5.10B
KGV:
24.85
EPS:
38.4657
Netto-Cashflow:
$5.41B
1W Leistung:
+4.40%
1M Leistung:
+8.42%
6M Leistung:
+10.42%
1J Leistung:
+25.17%
1-Tages-Spanne:
$936.77
$956.24
1-Wochen-Bereich:
$906.65
$956.24
52-Wochen-Spanne:
$723.68
$999.00
Mckesson Corp Stock (MCK) Company Profile
Firmenname
Mckesson Corp
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-19 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2026-04-28 | Eingeleitet | William Blair | Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corp Aktie (MCK) Neueste Nachrichten
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now - Zacks Investment Research
McKesson (MCK) Extends Key Distribution Tie Through 2032 And Expands Pharmacy Role - Simply Wall Street
McKesson Corporation (MCK) Stock forecasts - Yahoo Finance Singapore
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
How AI Adoption Could Supercharge McKesson (MCK) - Yahoo Finance Singapore
Here's Why McKesson (MCK) is a Strong Growth Stock - Zacks Investment Research
Here's Why McKesson (MCK) Fell More Than Broader Market - Zacks Investment Research
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Zacks Investment Research
What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal? - Yahoo Finance
Option Care stock surges on McKesson’s home-infusion bet - TheStreet
CD&R And McKesson To Acquire Option Care Health For $5.8 Billion - Pulse 2.0
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Yahoo Finance
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Zacks Investment Research
McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout - finchannel
McKesson, private equity firm buy home infusion company, Option Care Health - Managed Healthcare Executive
McKesson Just Put $32.05 Cash on America's Biggest Home Infusion Name - Money Morning
McKesson Corporation (MCK) Stock Forecasts - Yahoo Finance
Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid - Yahoo Finance
Why Option Care Health Stock Skyrocketed on Tuesday - The Motley Fool
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
CD&R, McKesson acquiring infusion therapy provider Option Care Health for $5.8B - Fierce Healthcare
McKesson, CD&R to buy Option Care Health for $5.8 billion - Modern Healthcare
Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share - Yahoo Finance
McKesson Buys Home Infusion Company Option Care for $5.8B - HomeCare
McKesson, CD&R to Buy Option Care in $5.8 Billion Deal - Bloomberg.com
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion - WSJ
CD&R, McKesson Corporation sign agreement to acquire Option Care Health - MLex
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ) - Seeking Alpha
Cd&R And Mckesson Corporation Sign Agreement To Acquire Option Care Health - TradingView
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health - Yahoo Finance
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Yahoo Finance
Option Care Jumps on Report McKesson Is Preparing an Offer - Bloomberg.com
McKesson and CD&R strike $5.8bn deal to buy infusion services provider - Financial Times
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
Company News for Oct 2, 2026 - Zacks Investment Research
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Zacks Investment Research
McKesson stock falls 1.19 percent as targets split - AD HOC NEWS
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued? - finance.yahoo.com
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
McKesson stock heads into the open after a 0.1 percent gain - AD HOC NEWS
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson 5-year return hits 34.23%, beating market by 22.21% - scanx.trade
Finanzdaten der Mckesson Corp-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mckesson Corp-Aktie (MCK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lerman Bradley E | Director |
Aug 10 '26 |
Sale |
892.33 |
301 |
268,590 |
0 |
| Lerman Bradley E | Director |
Aug 10 '26 |
Proposed Sale |
892.32 |
301 |
268,589 |
0 |
| Vitalone Britt J. | Former Officer |
Aug 03 '26 |
Proposed Sale |
843.31 |
7,925 |
6,683,192 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jul 07 '26 |
Sale |
793.56 |
8,463 |
6,715,898 |
5,919 |
| TYLER BRIAN S. | Officer |
Jul 07 '26 |
Proposed Sale |
793.56 |
8,463 |
6,715,898 |
0 |
| TYLER BRIAN S. | Officer |
Jun 17 '26 |
Proposed Sale |
775.13 |
8,463 |
6,559,925 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jun 17 '26 |
Sale |
775.13 |
8,463 |
6,559,925 |
14,382 |
| TYLER BRIAN S. | Officer |
Jun 09 '26 |
Proposed Sale |
763.00 |
4,929 |
3,760,827 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jun 09 '26 |
Sale |
763.00 |
4,929 |
3,760,827 |
22,845 |
| Rutledge Napoleon B JR | SVP, Controller & CAO |
Jun 05 '26 |
Sale |
764.00 |
133 |
101,612 |
632 |
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):